Drug surveillance is essential for monitoring the safety and effectiveness of medications after they are approved for public use. Post-marketing surveillance helps identify rare or long-term adverse drug reactions that may not have been evident in clinical trials. This ongoing monitoring ensures that the benefits of a drug continue to outweigh its risks.
